These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 34265421)
21. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents. Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis. Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds. Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367 [TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents. Desai NC; Trivedi AR; Somani HC; Bhatt KA Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents. Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of Novel Sulfamethaoxazole 4-Thiazolidinone Hybrids and Their Biological Evaluation. Bhat MA; Al-Omar MA; Naglah AM; Khan AA Molecules; 2020 Aug; 25(16):. PubMed ID: 32781534 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, biological evaluation and molecular dynamics of some novel 3-phenylpyrazolo[1,5- Chauhan M; Prajapati C; Mirza S; Barot R; Yadav R; Barmade M; Kakadiya D; Vijayvargia R; Haobam B; Baidya AT; Kumar R; Yadav MR; Murumkar P J Biomol Struct Dyn; 2024 Oct; 42(17):9031-9049. PubMed ID: 37655680 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis. Zhou S; Yang S; Huang G J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1183-1186. PubMed ID: 28870094 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity. Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antituberculosis activity of novel 5-styryl-4-(hetero)aryl-pyrimidines via combination of the Pd-catalyzed Suzuki cross-coupling and S(N)(H) reactions. Kravchenko MA; Verbitskiy EV; Medvinskiy ID; Rusinov GL; Charushin VN Bioorg Med Chem Lett; 2014 Jul; 24(14):3118-20. PubMed ID: 24856062 [TBL] [Abstract][Full Text] [Related]
31. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Komarova K; Vinogradova L; Lukin A; Zhuravlev M; Deniskin D; Chudinov M; Gureev M; Dogonadze M; Zabolotnykh N; Vinogradova T; Lavrova A; Yablonskiy P Molecules; 2024 Jun; 29(13):. PubMed ID: 38999023 [TBL] [Abstract][Full Text] [Related]
32. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids. Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670 [TBL] [Abstract][Full Text] [Related]
36. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents. Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585 [TBL] [Abstract][Full Text] [Related]
37. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria. Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053 [TBL] [Abstract][Full Text] [Related]
38. Riminophenazine Derivatives as Potential Antituberculosis Agents: Synthesis, Biological, and Electrochemical Evaluations. Bvumbi MV; van der Westhuyzen C; Mmutlane EM; Ngwane A Molecules; 2021 Jul; 26(14):. PubMed ID: 34299475 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and antitubercular activity of new L-serinyl hydrazone derivatives. Pinheiro AC; Kaiser CR; Nogueira TC; Carvalho SA; da Silva EF; Feitosa Lde O; Henriques Md; Candéa AL; Lourenço MC; de Souza MV Med Chem; 2011 Nov; 7(6):611-23. PubMed ID: 22313301 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents. Liu P; Yang Y; Tang Y; Yang T; Sang Z; Liu Z; Zhang T; Luo Y Eur J Med Chem; 2019 Feb; 163():169-182. PubMed ID: 30508666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]